Author

Luke Tso

UnitedHealth Group (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Aaron J. WilkiD· 1 shared Aimee BeckiD· 1 shared Arjun RustagiiD· 1 shared Brooke E. HowittiD· 1 shared Catherine A. BlishiD· 1 shared Chengkun WangiD· 1 shared Elif Tokar Erdemic· 1 shared Grace Peters-Schulze· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aaron J. WilkORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CRISPRa screening with real world evidence identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

Chengkun Wang, Ravi K. Dinesh, Yuanhao Qu, Arjun Rustagi, Henry C. Cousins, James R. Zengel, Tianyi Zhang, Nicholas Magazine, Yinglong Guo, Taryn O. Hall, Aimee Beck, Lucas Miecho Heilbroner, Grace Peters-Schulze, Aaron J. Wilk, Luke Tso, , Le Cong

The paper uses CRISPRa screening and real-world data to identify KCNA6 as a neuronal entry factor for SARS-CoV-2 and shows dalfampridine can suppress viral entry.

bioRxiv · Jul 1, 2021 · PreprintGenomics